These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34674508)

  • 1. Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea.
    Ku EJ; Lee C; Shim J; Lee S; Kim KA; Kim SW; Rhee Y; Kim HJ; Lim JS; Chung CH; Chun SW; Yoo SJ; Ryu OH; Cho HC; Hong AR; Ahn CH; Kim JH; Choi MH
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1131-1141. PubMed ID: 34674508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic changes in serum steroids for diagnosing and subtyping Cushing's syndrome.
    Ahn CH; Lee C; Shim J; Kong SH; Kim SJ; Kim YH; Lee KE; Shin CS; Kim JH; Choi MH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105856. PubMed ID: 33647522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease.
    Gao C; Ding L; Zhang X; Yuan M; Tang S; Li W; Ye Y; Liu M; He Q
    Front Endocrinol (Lausanne); 2023; 14():1158573. PubMed ID: 37260439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines.
    Noh J; Lee C; Kim JH; Myung SW; Choi MH
    J Lipid Res; 2023 Nov; 64(11):100453. PubMed ID: 37806496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Steroid Profiling Combined With Machine Learning for the Differential Diagnosis in Mild Autonomous Cortisol Secretion From Nonfunctioning Adenoma in Patients With Adrenal Incidentalomas.
    Mu D; Qian X; Ma Y; Wang X; Gao Y; Ma X; Xie S; Hou L; Zhang Q; Zhao F; Xia L; Lin L; Qiu L; Wu J; Yu S; Cheng X
    Endocr Pract; 2024 Jul; 30(7):647-656. PubMed ID: 38657794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension.
    Knuchel R; Erlic Z; Gruber S; Amar L; Larsen CK; Gimenez-Roqueplo AP; Mulatero P; Tetti M; Pecori A; Pamporaki C; Langton K; Peitzsch M; Ceccato F; Prejbisz A; Januszewicz A; Adolf C; Remde H; Lenzini L; Dennedy M; Deinum J; Jefferson E; Blanchard A; Zennaro MC; Eisenhofer G; Beuschlein F
    Front Endocrinol (Lausanne); 2024; 15():1370525. PubMed ID: 38596218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum steroid profiling by mass spectrometry in adrenocortical tumors: diagnostic implications.
    Fanelli F; Di Dalmazi G
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):160-165. PubMed ID: 30893084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotyping.
    Braun LT; Osswald A; Zopp S; Rubinstein G; Vogel F; Riester A; Honegger J; Eisenhofer G; Constantinescu G; Deutschbein T; Quinkler M; Elbelt U; Künzel H; Nowotny HF; Reisch N; Hartmann MF; Beuschlein F; Pons-Kühnemann J; Reincke M; Wudy SA
    EBioMedicine; 2024 Jan; 99():104907. PubMed ID: 38128413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism.
    Peitzsch M; Dekkers T; Haase M; Sweep FC; Quack I; Antoch G; Siegert G; Lenders JW; Deinum J; Willenberg HS; Eisenhofer G
    J Steroid Biochem Mol Biol; 2015 Jan; 145():75-84. PubMed ID: 25312486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC-MS/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol.
    Chang YL; Chen GY; Lee BC; Chen PT; Liu KL; Chang CC; Weng TI; Wu VC; Lin YH;
    Hypertens Res; 2023 Aug; 46(8):1983-1994. PubMed ID: 37311968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing's syndrome.
    Tateishi Y; Kouyama R; Mihara M; Doi M; Yoshimoto T; Hirata Y
    Endocr J; 2012; 59(4):283-9. PubMed ID: 22261010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors.
    Vogg N; Müller T; Floren A; Dandekar T; Riester A; Dischinger U; Kurlbaum M; Kroiss M; Fassnacht M
    Clin Chim Acta; 2023 Mar; 543():117301. PubMed ID: 36948238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
    Abe I; Sugimoto K; Miyajima T; Ide T; Minezaki M; Takeshita K; Takahara S; Nakagawa M; Fujimura Y; Kudo T; Miyajima S; Taira H; Ohe K; Ishii T; Yanase T; Kobayashi K
    Intern Med; 2018 Sep; 57(17):2467-2472. PubMed ID: 29709936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia.
    Hannah-Shmouni F; Berthon A; Faucz FR; Briceno JM; Maria AG; Demidowich A; Peitzsch M; Masjkur J; Bonnet-Serrano F; Vaczlavik A; Bertherat J; Reincke M; Eisenhofer G; Stratakis CA
    Endocr Relat Cancer; 2020 Jul; 27(7):403-413. PubMed ID: 32348959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism.
    Eisenhofer G; Dekkers T; Peitzsch M; Dietz AS; Bidlingmaier M; Treitl M; Williams TA; Bornstein SR; Haase M; Rump LC; Willenberg HS; Beuschlein F; Deinum J; Lenders JW; Reincke M
    Clin Chem; 2016 Mar; 62(3):514-24. PubMed ID: 26787761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum steroid profiling in Cushing's syndrome patients.
    Hána V; Ježková J; Kosák M; Kršek M; Hána V; Hill M
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105410. PubMed ID: 31201926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
    Velikanova LI; Shafigullina ZR; Lisitsin AA; Vorokhobina NV; Grigoryan K; Kukhianidze EA; Strelnikova EG; Krivokhizhina NS; Krasnov LM; Fedorov EA; Sablin IV; Moskvin AL; Bessonova EA
    Horm Cancer; 2016 Dec; 7(5-6):327-335. PubMed ID: 27370636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of serum dehydroepiandrosterone sulfate in differential diagnosis of Cushing's syndrome].
    Liu MS; Zhang WJ; Zhu KY; Chen H; Feng WH; Zhu DL; Li P
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2822-2827. PubMed ID: 32988141
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
    Berke K; Constantinescu G; Masjkur J; Kimpel O; Dischinger U; Peitzsch M; Kwapiszewska A; Dobrowolski P; Nölting S; Reincke M; Beuschlein F; Bornstein SR; Prejbisz A; Lenders JWM; Fassnacht M; Eisenhofer G
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1181-e1192. PubMed ID: 34665854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.